This slide presentation is part of a lecture by medical oncologist and lung cancer expert Dr. Jack West, in which he covers the optimal treatment strategies for locally advanced (stage III), unresectable NSCLC.

This slide presentation is part of a lecture by medical oncologist and lung cancer expert Dr. Jack West, in which he covers the optimal treatment strategies for locally advanced (stage III), unresectable NSCLC.

This slide presentation is part of a lecture by medical oncologist and lung cancer expert Dr. Jack West, in which he discusses the evidence supporting the current standard of adjuvant (post-operative) chemotherapy to improve survival for patients with early stage, resected NSCLC.

This slide presentation is part of a lecture by medical oncologist and lung cancer expert Dr. Jack West, in which he discusses the evidence supporting the current standard of adjuvant (post-operative) chemotherapy to improve survival for patients with early stage, resected NSCLC.

This interview by medical oncologist Dr. Jack West of Dr. Sarita Dubey, medical oncologist at UCSF Cancer Center, covers the evidence and ongoing questions about the role of chemotherapy in early stage NSCLC.

This interview by medical oncologist Dr. Jack West of Dr. Sarita Dubey, medical oncologist at UCSF Cancer Center, covers the evidence and ongoing questions about the role of chemotherapy in early stage NSCLC.

This slide presentation is part of a lecture by medical oncologist and lung cancer expert Dr. Jack West, in which he discusses current and investigational treatment options for relapsed small cell lung cancer, with a particular focus on amrubicin.

This slide presentation is part of a lecture by medical oncologist and lung cancer expert Dr. Jack West, in which he discusses current and investigational treatment options for relapsed small cell lung cancer, with a particular focus on amrubicin.

This interview by medical oncologist Dr. Jack West of Dr. Suresh Ramalingam, medical oncologist at Emory University in Atlanta, covers the evolving first line treatment standards of chemotherapy and targeted therapy for the first line treatment, as well as the emerging issue of maintenance therapy after initial treatment of advanced NSCLC.

This interview by medical oncologist Dr. Jack West of Dr. Suresh Ramalingam, medical oncologist at Emory University in Atlanta, covers the evolving first line treatment standards of chemotherapy and targeted therapy for the first line treatment, as well as the emerging issue of maintenance therapy after initial treatment of advanced NSCLC.

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West presents a general background on the distinct demographic, pathologic, molecular, and treatment outcome features seen among never-smokers with lung cancer.

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West presents a general background on the distinct demographic, pathologic, molecular, and treatment outcome features seen among never-smokers with lung cancer.

This interview by medical oncologist Dr. Jack West of Dr. Vivek Mehta, radiation oncologist Seattle, includes discussion of emerging radiation techniques to treat medically inoperable early stage lung cancer, the challenges of treating locally advanced NSCLC with chemo/radiation, and the role of radiation in advanced lung cancer.

This interview by medical oncologist Dr. Jack West of Dr. Vivek Mehta, radiation oncologist Seattle, includes discussion of emerging radiation techniques to treat medically inoperable early stage lung cancer, the challenges of treating locally advanced NSCLC with chemo/radiation, and the role of radiation in advanced lung cancer.

This interview by medical oncologist Dr. H. Jack West of oncology social worker Leah de Roulet covers several of the leading challenges for cancer patients and their families in coping with cancer and a terminal diagnosis. These difficulties include both emotional and practical concerns.

This interview by medical oncologist Dr. H. Jack West of oncology social worker Leah de Roulet covers several of the leading challenges for cancer patients and their families in coping with cancer and a terminal diagnosis. These difficulties include both emotional and practical concerns.

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the development of current standards and anticipated benefits vs. risks of second line chemotherapy for advanced non-small cell lung cancer (NSCLC).

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the development of current standards and anticipated benefits vs. risks of second line chemotherapy for advanced non-small cell lung cancer (NSCLC).

This interview by medical oncologist Dr. Jack West of lung cancer expert Toni Wozniak from Karmanos Cancer Institute at Wayne State University covers current standards for optimal management of small cell lung cancer (SCLC).